Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences